tuberculosis
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.
The AI model, HeAR, was created to help improve health outcomes for tuberculosis patients across India by 2030.
A first deployment at Sumedang regency will focus on addressing tuberculosis, stunting, and hypertension.
Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.
The model showed 86% sensitivity and a specificity of up to 96.1%.
The "JLD-02K" solution provides convenience to clinicians while also supporting higher precision of analysis.
The independent investigation suggests that wirelessly observed therapies using Proteus' system could be considered equivalent to in-person medication adherence programs, but much better received by patients taking oral medications.